RS
CRL icon

Rakuten Securities’s Charles River Laboratories CRL Stock Holding History

Rakuten Securities’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-4
Closed -$626 – 912
2025
Q3 		$626 Buy
4
+2
+100% +$318 ﹤0.01% 758
2025
Q2 		$303 Hold
2
– – ﹤0.01% 745
2025
Q1 		$301 Hold
2
– – ﹤0.01% 746
2024
Q4 		$369 Hold
2
– – ﹤0.01% 683
2024
Q3 		$394 Sell
2
-1
-33% -$208 ﹤0.01% 647
2024
Q2 		$620 Buy
3
+1
+50% +$227 ﹤0.01% 591
2024
Q1 		$542 Hold
2
– – ﹤0.01% 609
2023
Q4 		$473 Buy
+2
New +$393 ﹤0.01% 523

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Rakuten Securities's CRL Position: Q4 2025 in Review

Rakuten Securities sold out of Charles River Laboratories (CRL) in Q4 2025, closing a stake of 4 shares — an estimated $626 sold.

Rakuten Securities first reported a position in CRL in Q4 2023 and held it in 8 quarters. The position peaked at $626 in Q3 2025. 583 funds tracked by Wall St. Rank hold CRL as of Q4 2025.

  • Rakuten Securities reported no remaining Charles River Laboratories position as of Q4 2025 after selling out during the quarter.
  • Rakuten Securities sold 4 Charles River Laboratories shares in Q4 2025, an estimated $626.
  • Rakuten Securities first reported a position in Charles River Laboratories in Q4 2023 and held it in 8 quarters.
  • Rakuten Securities's Charles River Laboratories position peaked at $626 in Q3 2025.
  • 583 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2025.

Based on Rakuten Securities's 13F filing for Q4 2025, filed 29 Jan 2026.